NCT01540604已完成2 期
An Open-label, Un-controlled, Single-centre Trial Investigating the Efficacy and Safety of CRD007 in Children With Duchenne Muscular Dystrophy (DMD) or Becker Muscular Dystrophy (BMD) or Children Being Symptomatic Carriers for DMD or BMD
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
研究概览
简要总结
This is an investigation of the efficacy and safety of CRD007 in Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy (BMD) and symptomatic carriers.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 Years 至 11 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Documented diagnosis of dystrophinopathy
排除标准
- •Severe functional impairment
研究组 & 干预措施
CRD007 10 mg tablet
Experimental
干预措施: CRD007 (Drug)
研究者
相似试验
已完成
2 期
HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)Duchenne Muscular DystrophyCardiomyopathyNCT02485938Capricor Inc.25
已完成
3 期
Finding the Optimum Regimen for Duchenne Muscular DystrophyDuchenne Muscular DystrophyNCT01603407University of Rochester196
已完成
1 期
Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular DystrophyMuscular Dystrophy, DuchenneNCT00243789Cooperative International Neuromuscular Research Group64
已完成
2 期
CRD007 for the Treatment of Abdominal Aorta Aneurysm (The AORTA Trial)Abdominal Aortic AneurysmNCT01354184RSPR Pharma AB
进行中（未招募）
不适用
Efficacy and Safety of D005 Vaginal Mousse on Bacterial VaginosisBacterial Vaginosis | Vaginal | MicrobiologyNCT04489290Pharmiva AB83